The current status of the treatment of ductal carcinoma in situ of Japanese women, especially breast conserving operation in relation to the surgical margin and short term outcome

Breast Cancer

Volumn 5, Issue 1, 1998, Pages 53-58

  Ikeda, Tadashi ^a   Akiyama, Futoshi ^b   Hiraoka, Masahiro ^c   Inaji, Hideo ^d   Ohuchi, Noriaki ^e   Takatsuka, Yuichi ^f   Yoshimoto, Masataka ^g  

^a KEIO UNIVERSITY   (Japan)

^b CANCER INSTITUTE   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^e TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f KANSAI ROSAI HOSPITAL   (Japan)

^g Cancer Institute Hospital   (Japan)

Author keywords

Breast cancer; Breast conserving operation; Ductal carcinoma in situ; Outcome; Surgical margin

Indexed keywords

EID: 0003112091     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/BF02967415     Document Type: Article

References (24)

1. Kurtz JM: Factors influencing the risk of local recurrence in the breast. Eur J Cancer 28:660-666, 1992.
2. Smitt MC, Nowels KW, Zdeblick MJ, et al: The importance of the lumpectomy surgical margin status in long term results of breast conservation. Cancer 76:259-267, 1995.
3. NIH consensus conference; Treatment of early-stage breast cancer. JAMA 265:391-395, 1991.
4. Silverstein MJ, Gierson ED, Colburn WJ, et al: Can intraductal breast carcinoma be excised completely by local excision? Clinical and pathologic predictors. Cancer 73:2985-2989, 1994. (Pubitemid 24170772)
5. Fisher B, Costantino J, Redmond C, et al: Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med 328:1581-1586, 1993. (Pubitemid 23151917)
6. Lagios MD: Duct carcinoma in situ; Biological implications for clinical practice. Semin Oncol 23(Suppl 2):6-11, 1996. (Pubitemid 26105765)
7. Talamonti MS: Management of ductal carcinoma in situ. Semin Surg Oncol 12:300-313, 1996. (Pubitemid 26300008)
8. Ernster VL, Barclay J, Kerlikowske K, et al: Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 275:913-918, 1996. (Pubitemid 26095381)
9. Morrow M: The natural history of ductal carcinoma in situ; Implications for clinical decision making. Cancer 76:1113-1115, 1995.
10. Hughes KS, Lee AK, Rolfs A: Controversies in the treatment of ductal carcinoma in situ. Surg Clin North Am 76:243-265, 1996. (Pubitemid 26119147)
11. Stotter AT, McNeese MD, Ames FC, et al: Predicting the rate and extent of locoregional failure after breast conservation therapy for early breast cancer. Cancer 64:2217-2225, 1989. (Pubitemid 19282834)
12. Van Dongen JA, Holland R, Peters JL, et al: Ductal carcinoma in situ of the breast; Second EORTC Consensus Meeting. Eur J Cancer 28:626-629, 1992.
13. Solin L, Kurtz J, Fourquet A, et al: Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. J Clin Oncol 14:754-763, 1996. (Pubitemid 26085518)
14. Wood WC: Management of lobular carcinoma in situ and ductal carcinoma in situ of the breast. Semin Oncol 23:446-452, 1996. (Pubitemid 26277434)
15. Fisher ER, Costantino J, Fisher B, et al: Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Cancer 75:1310-1319, 1995.
16. Page DL, Lagios MD: Pathologic analysis of the National Surgical Adjuvant Breast Project (NSABP) B-17 Trial; Unanswered questions remaining unanswered considering current concepts of ductal carcinoma in situ (Editorial). Cancer 75:1219-1222, 1995.
17. Frykberg ER, Bland KI: Management of in situ and minimally invasive breast carcinoma. World J Surg 18:45-57, 1994. (Pubitemid 24100692)
18. Holland R, Hendriks JH, Verbeek AL, et al: Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ. Lancet 335:519-522, 1990. (Pubitemid 20073065)
19. Fourquet A, Campana F, Zafrani B, et al: Prognostic factors of breast recurrence in the conservative management of early breast cancer; A 25-year follow-up. Int J Radiat Oncol Biol Phys 17:719-725, 1989. (Pubitemid 19250523)
20. Kurtz JM, Jacquemier J, Amalric R, et al: Why are local recurrences after breast-conserving therapy more frequent in younger patients? J Clin Oncol 8:591-598, 1990. (Pubitemid 20127241)
21. Ikeda T, Enomoto K, Wada K, et al: Frozen-sectionguided breast-conserving surgery; Implications of diagnosis by frozen section as a guide to determining the extent of resection. Surg Today 27:207-212, 1997. (Pubitemid 27150119)
22. Ikeda T, Enomoto K, Fujiwara K, et al: Factors influencing positive surgical margin in breast conserving operation. In: Abe O, Inokuchi K, Takasaki K eds, XXX World Congress of The International College of Surgeons, Monduzzi Editore Co, pp1463-1468, 1996.
23. Yamakawa T, Shinotoh M, Taniki T, et al: Ductal carcinoma in situ of the breast; Is breast conserving treatment feasible? Breast Cancer 3:119-123, 1996.
24. Page D, Dupont WD, Rogers LW, et al: Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated